January 10, 2019

Inflammatory markers in Alzheimer’s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies

Key Points

Key points are not available for this paper at this time.

Abstract

Significantly altered levels of inflammatory markers were verified in comparison between AD, MCI and control, supporting the notion that AD and MCI are accompanied by inflammatory responses in both the periphery and CSF.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Shen et al. (Thu,) studied this question.

synapsesocial.com/papers/69da25f6b48bb130d46845ba https://doi.org/https://doi.org/10.1136/jnnp-2018-319148

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of peripheral inflammatory markers between normal control and Alzheimer's disease2011 · 69 citations
2Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment2002 · 100 citations
3Oral Infections and Cytokine Levels in Patients with Alzheimer’s Disease and Mild Cognitive Impairment Compared with Controls2016 · 84 citations
4Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment2004 · 4,979 citations
5A Meta-Analysis of Cytokines in Alzheimer's Disease2010 · 1,112 citations

Demander à l'IA

Bookmark

View Full Paper